Skip to content

NGEN

NervGen Pharma Corp.

NASDAQ · Healthcare · Biotechnology · CA

$2.05
−9.69%
Ask drillr

Margins

Gross margin
EBITDA margin
EBIT margin
Net margin
FCF margin
-390.4%
Return on equity
-74.8%
Return on assets
-219.9%
Return on invested capital
0.00x
Asset turnover
-$21.2M
Cash from operations
$0.58
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026